S2T (p.Ser2Thr) variant of OPTN (Optineurin)
S2T (p.Ser2Thr) in OPTN (Optineurin) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact.
S2T (p.Ser2Thr) variant details
- p.Ser2Thr
- NCI-TCGA TCGA novel
- Variant assessed as somatic; moderate impact.
- Missense
- UniProt: Variant assessed as somatic; moderate impact.